Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Am J Transplant. 2010 Mar;10(3):518-526. doi: 10.1111/j.1600-6143.2009.02967.x. Epub 2010 Feb 1.
Induction of mixed allogeneic chimerism is a promising approach for achieving donor-specific tolerance, thereby obviating the need for life-long immunosuppression for solid organ allograft acceptance. In mice receiving a low dose (3Gy) of total body irradiation, allogeneic bone marrow transplantation combined with anti-CD154 tolerizes peripheral CD4 and CD8 T cells, allowing achievement of mixed chimerism with specific tolerance to donor. With this approach, peripheral CD8 T-cell tolerance requires recipient MHC class II, CD4 T cells, B cells and DCs. Recipient-type B cells from chimeras that were tolerant to donor still promoted CD8 T-cell tolerance, but their role could not be replaced by donor-type B cells. Using recipients whose B cells or DCs specifically lack MHC class I and/or class II or lack CD80 and CD86, we demonstrate that dendritic cells (DCs) must express CD80/86 and either MHC class I or class II to promote CD8 tolerance. In contrast, B cells, though required, did not need to express MHC class I or class II or CD80/86 to promote CD8 tolerance. Moreover, recipient IDO and IL-10 were not required. Thus, antigen presentation by recipient DCs and not by B cells is critical for peripheral alloreactive CD8 T cell tolerance.
诱导混合同种嵌合体是实现供者特异性耐受的一种很有前途的方法,从而避免了实体器官移植接受者需要终身免疫抑制。在接受低剂量(3Gy)全身照射的小鼠中,同种异体骨髓移植联合抗 CD154 可使外周 CD4 和 CD8 T 细胞耐受,从而实现具有供者特异性耐受的混合嵌合体。采用这种方法,外周 CD8 T 细胞耐受需要受者 MHC Ⅱ类、CD4 T 细胞、B 细胞和 DC。对供者具有耐受性的嵌合体中的受者来源 B 细胞仍然促进 CD8 T 细胞耐受,但它们的作用不能被供者来源 B 细胞替代。使用 B 细胞或 DC 特异性缺乏 MHC Ⅰ类和/或Ⅱ类或缺乏 CD80 和 CD86 的受者,我们证明 DC 必须表达 CD80/86 以及 MHC Ⅰ类或Ⅱ类以促进 CD8 耐受。相反,B 细胞虽然是必需的,但不需要表达 MHC Ⅰ类或Ⅱ类或 CD80/86 来促进 CD8 耐受。此外,受者 IDO 和 IL-10 也不是必需的。因此,受者 DC 而不是 B 细胞的抗原呈递对于外周同种反应性 CD8 T 细胞耐受至关重要。